Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study
Elizabeth R. Plimack*, Joaquim Bellmunt, Shilpa Gupta, Raanan Berger, Laura Q.M. Chow, Jonathan Juco, Jared Lunceford, Sanatan Saraf, Rodolfo F. Perini, Peter H. O'Donnell
Research output: Contribution to journal › Article › peer-review
300Scopus
citations
Fingerprint
Dive into the research topics of 'Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study'. Together they form a unique fingerprint.